Literature DB >> 33585123

Hepatocellular Carcinoma Misdiagnosed as a Liver Abscess - A Story of Misdiagnosis and Long-Term Malignant Disease Control.

Ahmed Mahmoud1, Kellee Slater1.   

Abstract

Hepatocellular carcinoma (HCC) is the most common liver malignancy. The presentation of HCC is highly variable which can delay diagnosis. However, the early diagnosis of HCC can significantly improve prognosis. A rare presentation of a patient with a new diagnosis of HCC with sepsis is described. A 56-year-old male presented septic with abdominal pain and a background of a chronic foot infection. The septic screen identified echocardiographic evidence of vegetations on the aortic and mitral leaflets. Also, an ultrasound of the abdomen identified multiple hypoechoic lesions suspicious for liver abscesses. Multiple attempts of ultrasound-guided aspiration of liver lesions were unsuccessful and he had a tumultuous course with recurring fevers over a period of six months. The diagnosis of HCC was eventually confirmed after the lesion eroded into his anterior gastric wall which caused an upper gastrointestinal bleed. He responded well to transarterial chemoembolization (TACE) and palliative radiation therapy. At four-year follow-up and after 11 TACE procedures, he is well without liver dysfunction and independent with daily activities.
Copyright © 2021, Mahmoud et al.

Entities:  

Keywords:  hepatocellular carcinoma (hcc); liver abcess; liver masses; transarterial chemoembolization (tace)

Year:  2021        PMID: 33585123      PMCID: PMC7872887          DOI: 10.7759/cureus.12636

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

Review 2.  Hepatocellular carcinoma.

Authors:  S Badvie
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

3.  Outcomes of emergency treatment in ruptured hepatocellular carcinoma in the ED.

Authors:  Wei-kung Chen; Yu-Tein Chang; Yun-ting Chung; Horng-ren Yang
Journal:  Am J Emerg Med       Date:  2005-10       Impact factor: 2.469

Review 4.  Rupture of Hepatocellular Carcinoma: A Review of Literature.

Authors:  Srimanta K Sahu; Yogesh K Chawla; Radha K Dhiman; Virendra Singh; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi
Journal:  J Clin Exp Hepatol       Date:  2018-04-26

Review 5.  Epidemiology and clinical presentation of hepatocellular carcinoma.

Authors:  Adrian M Di Bisceglie
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

Review 6.  Hepatocellular carcinoma: A comprehensive review.

Authors:  Lisa P Waller; Vrushak Deshpande; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2015-11-18

Review 7.  Epidemiology and Management of Hepatocellular Carcinoma.

Authors:  Laura Kulik; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-10-24       Impact factor: 22.682

8.  Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.

Authors:  Nicole E Rich; Caitlin C Murphy; Adam C Yopp; Jasmin Tiro; Jorge A Marrero; Amit G Singal
Journal:  Aliment Pharmacol Ther       Date:  2020-06-29       Impact factor: 9.524

9.  Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.

Authors:  Jie-Yu Kong; Shu-Mei Li; Hai-Yan Fan; Lan Zhang; Hui-Jin Zhao; Sheng-Mian Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

10.  Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study.

Authors:  Guoyi Wu; Jing Wu; Baohua Wang; Xiaolei Zhu; Xiaolei Shi; Yitao Ding
Journal:  Cancer Manag Res       Date:  2018-10-10       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.